Medium materiality6/10
BridgeBio Pharma price target lowered to $156 from $157 at Barclays
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lowered BridgeBio's price target to 156 from 157; current price 66.96; priceChangeSinceSignal -2.4; directional setup bearish.
- BBIO target cut to 156; price 66.96; -2.4% since signal
Key facts
- 01
Target: $156
- 02
Posted price: $66.96
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.